Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

Businessman touching on number 2022 for preparation
Investing Articles

1 FTSE 100 stock I’d buy with £1k for 2022

| Manika Premsingh

The FTSE 100 stock has been a rewarding one for this Fool in the past. And going by its results…

Read more »

A GlaxoSmithKline scientist uses a microscope
Investing Articles

Should I act on the GlaxoSmithKline share price or buy AstraZeneca instead?

| Christopher Ruane

Our writer considers whether the GlaxoSmithKline share price could make it an attractive addition for his portfolio, compared to rival…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

Why AstraZeneca stock is a buy right now

| Ed Jones

Fool contributor Ed Jones provides three reasons why he's bullish on AstraZeneca stock and is considering adding it to his…

Read more »

Investing Articles

2022 dividend forecasts: HSBC, AstraZeneca, Glencore

| Roland Head

These FTSE 100 stocks are popular income picks, but how much will they payout in 2022? Roland Head looks at…

Read more »

Investing Articles

1 FTSE 100 stock I wouldn’t miss buying in November

| Manika Premsingh

This FTSE 100 stock has seen a decline in share price in recent months. But that might be about to…

Read more »

Investing Articles

2 FTSE 100 dividend stocks I’d aim to never sell

| Kevin Godbold

I wouldn't try to hold all my investments forever, but these two FTSE 100 dividend stocks both have many qualities…

Read more »

Syringe and vial on blue background
Investing Articles

AstraZeneca (LON:AZN) makes progress in the fight against liver cancer

| Zaven Boyrazian, CFA

The AstraZeneca (LON:AZN) share price idles despite the firm reporting positive results from its liver cancer clinical trials.

Read more »

Investing Articles

These 2 FTSE 100 stocks are beaten down bargains in my opinion!

| Jabran Khan

This Fool identifies two FTSE 100 picks he believes are beaten down stocks that could be potential bargains with upside…

Read more »

Investing Articles

Why I’d buy AstraZeneca shares today

| Alexander Fazel

AstraZeneca shares have rallied since the vaccine rollout. As we move into a post-pandemic world, I discuss why AstraZeneca piques…

Read more »

Investing Articles

3 FTSE 100 stocks to buy for the long term

| Manika Premsingh

These FTSE 100 stocks are among the biggest gainers today, but this Fool reckons that their long-term prospects are good…

Read more »

Investing Articles

2 UK shares to buy now for growth

| Christopher Ruane

From his list of top UK shares to buy now for his portfolio, our writer considers two firms whose growth…

Read more »

Investing Articles

AstraZeneca (AZN) shares gain on acquisition news

| Alan Oscroft

AstraZeneca (LON: AZN) expands its presence in rare disease development with a further acquisition, sending its shares higher.

Read more »